Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Asset Writedowns and Impairment (2018 - 2025)

Historic Asset Writedowns and Impairment for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to $632000.0.

  • Bio's Asset Writedowns and Impairment fell 351.15% to $632000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year increase of 4780.86%. This contributed to the annual value of $3.0 million for FY2024, which is 10898.16% up from last year.
  • Bio's Asset Writedowns and Impairment amounted to $632000.0 in Q3 2025, which was down 351.15% from $280000.0 recorded in Q2 2025.
  • Bio's Asset Writedowns and Impairment's 5-year high stood at $1.4 million during Q4 2024, with a 5-year trough of $57000.0 in Q4 2022.
  • Moreover, its 5-year median value for Asset Writedowns and Impairment was $560000.0 (2024), whereas its average is $485052.6.
  • In the last 5 years, Bio's Asset Writedowns and Impairment plummeted by 7237.57% in 2021 and then soared by 64035.09% in 2023.
  • Over the past 5 years, Bio's Asset Writedowns and Impairment (Quarter) stood at $105000.0 in 2021, then crashed by 45.71% to $57000.0 in 2022, then soared by 640.35% to $422000.0 in 2023, then surged by 229.86% to $1.4 million in 2024, then plummeted by 54.6% to $632000.0 in 2025.
  • Its last three reported values are $632000.0 in Q3 2025, $280000.0 for Q2 2025, and $630000.0 during Q1 2025.